Peptide-mediated targeting of liposomes to TrkB receptor-expressing cells

Sanjeev Ranjan1, Rohit Sood, Jozsef Dudas

  • 1Helsinki Biophysics and Biomembrane Group, Department of Biomedical Engineering and Computational Science, Aalto University, Espoo, Finland.

Abstract

Insights

Targeted liposomes effectively bind and are internalized by TrkB-expressing cells. This peptide-conjugated liposome (PCL) delivery system shows promise for TrkB-targeted therapies in neuroblastoma and other cancers.

Area of Science:

  • Cell biology
  • Nanomedicine
  • Biotechnology

Background:

  • The neurotrophic receptor tyrosine kinase B (TrkB) plays critical roles in both neuronal survival and tumor cell signaling, making it a target for neuroblastoma and other cancers.
  • TrkB's dual role necessitates targeted delivery strategies for therapeutic intervention, balancing its function in neurons versus tumor cells.

Purpose of the Study:

  • To investigate the feasibility of targeting TrkB-expressing cells using peptide-conjugated liposomes (PCL).
  • To evaluate the binding and internalization efficiency of TrkB-targeted PCL in relevant cell models.

Main Methods:

  • Utilized flow cytometry and confocal fluorescence microscopy to monitor PCL binding and internalization.
  • Employed TrkB-expressing mouse macrophage-like RAW264 cells and human neuroblastoma SH-SY5Y cells (treated with all-trans-retinoic acid).

Main Results:

  • TrkB-targeted PCL demonstrated enhanced and faster internalization by RAW264 cells compared to scrambled peptide controls.
  • Augmented binding and uptake of targeted PCL were observed in TrkB-positive SH-SY5Y cells, with cytoplasmic localization within 20 minutes.

Conclusions:

  • Demonstrated the successful targeting of liposomes to TrkB-expressing cells using 18-mer peptides.
  • Confirmed that targeted PCL promotes cellular uptake, at least partially into endosomes, via receptor-mediated pathways.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.